Amrita Bobok - Concepedia

Author

Amrita Bobok

Gedeon Richter (Hungary)

Also Known As

Amrita Bobok, Amrita Á. Bobok, Amrita Ágnes Bobok

Publications

278

Citations

H-Index

Concepts

All Affiliations

Gedeon Richter (Hungary)HUN-REN Research Centre for Natural Sciences

About

Amrita Bobok is an author at Gedeon Richter (Hungary) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	142
2	Biochemistry	3	3	61
3	Social Sciences	2	2	58
4	Engineering	1	1	20
5	Cell Biology	1	1	11

Amrita Bobok

Publications

186

Citations

H-Index

Page 1

	Year	Citations
Poster #16 CARIPRAZINE, A D3/D2 DOPAMINE RECEPTOR PARTIAL AGONIST ANTIPSYCHOTIC, DISPLAYS GREATER D3 RECEPTOR OCCUPANCY IN VIVO COMPARED WITH OTHER ANTIPSYCHOTICS Béla Kiss, Ferenc Horti, Amrita Bobok Schizophrenia Research PsychiatryMedicinePsychotropic MedicationPsychopharmacologySchizophrenia	2012	29
In vitro and in vivo comparison of [<sup>3</sup>H](+)‐PHNO and [<sup>3</sup>H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: A method to distinguish dopamine D<sub>3</sub>from D<sub>2</sub>receptor sites: A method to distinguish dopamine D<sub>3</sub>from D<sub>2</sub>receptor sites Béla Kiss, Ferenc Horti, Amrita Bobok Synapse	2010	29
Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications János Galambos, Attila Bielik, Mikhail Krasavin, Journal of Medicinal Chemistry Psychiatric IndicationsHigh ThroughputPsychopharmacologyPharmacotherapySocial Sciences	2017	29
Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists János Galambos, Gábor Wágner, Katalin Nógrádi, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryFunctional SelectivityMedicineMechanism Of Action	2010	21
4-Aryl-3-arylsulfonyl-quinolines as negative allosteric modulators of metabotropic GluR5 receptors: From HTS hit to development candidate János Galambos, György Domány, Katalin Nógrádi, Bioorganic & Medicinal Chemistry Letters Negative Allosteric ModulatorsSignal TransductionG Protein-coupled ReceptorMetabotropic Glur5 ReceptorsDevelopment Candidate	2016	21
Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs Gábor Wágner, Csaba Wéber, O. Nyéki, Bioorganic & Medicinal Chemistry Letters Chemical EngineeringEngineeringMedicineOrganic ChemistryChemistry	2010	20
Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: Lead optimization Katalin Nógrádi, Gábor Wágner, György Domány, Bioorganic & Medicinal Chemistry Letters	2015	15
Thieno[2,3-b]pyridines as negative allosteric modulators of metabotropic GluR5 receptors: Hit-to-lead optimization Katalin Nógrádi, Gábor Wágner, György Domány, Bioorganic & Medicinal Chemistry Letters Negative Allosteric ModulatorsBiochemistryFunctional SelectivityMetabotropic Glur5 ReceptorsMedicine	2014	11
Cell-based and virtual fragment screening for adrenergic α2C receptor agonists Edit Szőllősi, Amrita Bobok, László Kiss, Bioorganic & Medicinal Chemistry Adrenal GlandSignal TransductionMolecular PhysiologyFunctional SelectivityMedicine	2015	11

Page 1